Chief Physician, Professor, Head of the Bladder Tumor Specialty Group.
Affiliated HospitalRenji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Research Areas : Personalized treatment and comprehensive treatment guided by molecular subtyping for bladder cancer. Cutting-edge Technologies: Pioneered in China completely laparoscopic orthotopic neobladder resection and da Vinci robot-assisted total cystectomy; based on molecular subtyping, chemotherapy, immunotherapy, or surgical options are selected, increasing the conversion resection rate of advanced bladder cancer to 75%.
Areas of expertise: Muscle-invasive bladder cancer, high-risk non-invasive bladder tumors, pelvic lymph node dissection and urinary diversion. Academic highlights: Over 0 SCI-indexed publications; multiple clinical studies cited in the European Association of Urology (EAU) guidelines.